Protherics PLC
Block Listing Six Monthly Return
6% Unsecured Convertible Loan Notes
London, UK; Brentwood, TN, US: 8 August 2008 - Protherics PLC
("Protherics" or the "Company"), the international biopharmaceutical
company focused on critical care and cancer, in accordance with Listing
Rule 3.5.6, notifies the following details in respect of a block
listing for the Company's 6% Unsecured Convertible Loan Notes:
Name of applicant: Protherics PLC
Name of scheme: Block Listing in respect
of 6% Unsecured Convertible Loan
Notes
Period of return: From: 9 February 2008 To: 8 August 2008
Balance of unallotted 8,430,060 Ordinary Shares (Loan
securities under scheme from Notes to the value of GBP2,107,515)
previous return:
The amount by which the block Nil
scheme has been increased since the
date of the last return:
Number of securities issued/
allotted under scheme during
period: 292,388 Ordinary Shares (Loan Notes
to the value of GBP73,097)
Balance under scheme not yet issued
/allotted at end of period
8,137,672 Ordinary Shares (Loan
Notes to the value of GBP2,034,418)
Number 17,092,476 Ordinary Shares (Loan
and class of securities originally Notes to the value of GBP4,273,119)
listed and the date of admission admitted on 8 February 2005
Total number of securities in issue 342,159,034 Ordinary Shares
at the end of the period
/ Ends /
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0)1928 518010
Financial Dynamics - press enquiries
London: Ben Atwell, Lara Mott +44 (0) 20 7831 3113
New York: John Capodanno +1 212 850 5600
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
Contact Information: Contacts: RNS Customer Services 0044-207797-4400 http://www.rns.com